Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.

Looking to boost your income from home? These 15 legitimate work-from-home jobs pay $75,000 or more a year, offering ...

A holistic financial plan goes beyond—here’s how to approach it.

MOST retirees worry about whether their money will last. Market swings, rising costs and unexpected expenses can turn what ...

Discover expert tips on advising clients about mortgage refinancing, considering current low-interest rates and ...

The billionaire family’s SGH conglomerate wants to split the steel-making giant and operate its Australian assets, and ...

A financial advisor who helped a Lincoln businessman swindle $45 million from nearly 20 banks and savings and loans was ...

In both Venezuela and Greenland, the Trump administration is proposing taxpayer-funded grabs of oil and rare earths so that ...

An elderly couple was swindled out of their $1.3 million retirement fund by scammers pretending to be representatives from ...

Scammers impersonating Amazon, TD Bank, and the FTC convinced retirees to convert $1.3 million into bitcoin and gold. The ...

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

A Valley woman says she was caught in the middle of an elaborate scam, nearly paying more than $1,000 as a security deposit ...